NCT06228326
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06228326
Title A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs (KYANITE-1)
Acronym KYANITE-1
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Krystal Biotech, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
XCancer Research Network/Dothan Hematology & Oncology RECRUITING Dothan Alabama 36303 United States Details
HonorHealth Research Institute RECRUITING Scottsdale Arizona 85258 United States Details
Precision NextGen Oncology RECRUITING Beverly Hills California 90212 United States Details
Emad Ibrahim MD Inc RECRUITING Redlands California 92373 United States Details
BRCR Global RECRUITING Weston Florida 33326 United States Details
IU Simon Comprehensive Cancer Center TERMINATED Indianapolis Indiana 46202 United States Details
Ochsner/MD Anderson Cancer Center RECRUITING New Orleans Louisiana 70121 United States Details
Henry Ford Health RECRUITING Detroit Michigan 48202 United States Details
Gabrail Cancer Center Research RECRUITING Canton Ohio 44718 United States Details
Cleveland Clinic RECRUITING Cleveland Ohio 44195 United States Details
UPMC Hillman Cancer Center TERMINATED Pittsburgh Pennsylvania 15232 United States Details
Sarah Cannon Research Institute RECRUITING Nasville Tennessee 37203 United States Details
Renovatio Clinical TERMINATED El Paso Texas 79915 United States Details
Renovatio Clinical TERMINATED The Woodlands Texas 77380 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field